Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Daridorexant hydrochloride by Idorsia Pharmaceutical for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Daridorexant hydrochloride is under clinical development by Idorsia Pharmaceutical and currently in Phase II for Post-Traumatic Stress Disorder (PTSD). According...
Daridorexant hydrochloride by Idorsia Pharmaceutical for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Daridorexant hydrochloride is under clinical development by Idorsia Pharmaceutical and currently in Phase II for Post-Traumatic Stress Disorder (PTSD). According...
Daridorexant hydrochloride by Idorsia Pharmaceutical for Obstructive Sleep Apnea: Likelihood of Approval
Daridorexant hydrochloride is under clinical development by Idorsia Pharmaceutical and currently in Phase I for Obstructive Sleep Apnea. According to...